Andrew L. Ross serves as Executive at iSpecimen Inc., where they oversee executive responsibilities. Since joining the company, Andrew L. Ross has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 1, 2023 involved receiving (via award) 125 shares valued at $0.
Andrew L. Ross currently holds 1,326,340 shares of iSpecimen Inc. (ISPC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew L. Ross has been a net neutral trader of ISPC stock. They have purchased $0 and sold $0 worth of shares.
Andrew L. Ross's most recent insider trade was on Jan 1, 2023, when they sold 125 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 21, 2021 | ISPC | $0 | Conversion | 360,674 | $N/A | Discretionary |
| Jun 21, 2021 | ISPC | $0 | Conversion | 86,438 | $N/A | Discretionary |
| Jun 21, 2021 | ISPC | $0 | Conversion | 13,985 | $N/A | Discretionary |
| Jun 21, 2021 | ISPC | $0 | Conversion | 130,081 | $N/A | Discretionary |
| Jun 21, 2021 | ISPC | $0 | Conversion | 355,005 | $N/A | Discretionary |